Comorbidities in rheumatoid arthritis

M Dougados - Current opinion in rheumatology, 2016 - journals.lww.com
Several comorbidities are frequently observed in rheumatoid arthritis because of the
persistent activity of the disease and/or because of the administered antirheumatic …

A systematic review and metaanalysis of antirheumatic drugs and vaccine immunogenicity in rheumatoid arthritis

S Subesinghe, K Bechman, AI Rutherford… - The Journal of …, 2018 - jrheum.org
Objective. Vaccination is a key strategy to reduce infection risk in patients with rheumatoid
arthritis (RA) and is advocated in internationally recognized rheumatology society …

The value of glucocorticoid co-therapy in different rheumatic diseases-positive and adverse effects

MC Van der Goes, JW Jacobs, JW Bijlsma - Arthritis research & therapy, 2014 - Springer
Glucocorticoids play a pivotal role in the management of many inflammatory rheumatic
diseases. The therapeutic effects range from pain relief in arthritides, to disease-modifying …

Key advances in the clinical approach to ANCA-associated vasculitis

CGM Kallenberg - Nature Reviews Rheumatology, 2014 - nature.com
The updated nomenclature for vasculitis defines this varied group of disorders by aetiology,
specific features of pathogenesis and clinical symptoms; diagnostic and classification criteria …

Impact of a nurse-led programme on comorbidity management and impact of a patient self-assessment of disease activity on the management of rheumatoid arthritis …

M Dougados, M Soubrier, E Perrodeau… - Annals of the …, 2015 - ard.bmj.com
Objectives Rheumatoid arthritis (RA) patients are at an increased risk of developing
comorbid conditions. A close monitoring of the disease targeting a status of low disease …

Comorbidities in patients with rheumatoid arthritis and their association with patient-reported outcomes: results of claims data linked to questionnaire survey

AL Ramos, I Redeker, F Hoffmann, J Callhoff… - The Journal of …, 2019 - jrheum.org
Objective. To investigate the prevalence of comorbidities in a population-based cohort of
persons with rheumatoid arthritis (RA) compared to matched controls and to examine their …

Systemic lupus erythematosus: state of the art on clinical practice guidelines

F Tamirou, L Arnaud, R Talarico, CA Scirè… - RMD open, 2019 - rmdopen.bmj.com
Systemic lupus erythematosus (SLE) is the paradigm of systemic autoimmune diseases
characterised by a wide spectrum of clinical manifestations with an unpredictable relapsing …

[HTML][HTML] Rituximab in autoimmune diseases

KL Randall - Australian prescriber, 2016 - ncbi.nlm.nih.gov
Rituximab in autoimmune diseases - PMC Back to Top Skip to main content NIH NLM Logo
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation Preview …

American College of Rheumatology Guidance for COVID‐19 vaccination in patients with rheumatic and musculoskeletal diseases: version 5

JR Curtis, SR Johnson, DD Anthony… - Arthritis & …, 2023 - Wiley Online Library
Objective To provide guidance to rheumatology providers on the use of COVID‐19 vaccines
for patients with rheumatic and musculoskeletal diseases (RMDs). Methods A task force was …

Rituximab and abatacept but not tocilizumab impair antibody response to pneumococcal conjugate vaccine in patients with rheumatoid arthritis

M Crnkic Kapetanovic, T Saxne, G Jönsson… - Arthritis research & …, 2013 - Springer
Introduction The objective of the study was to investigate the impact of newer biologic
treatments including rituximab, abatacept and tocilizumab on antibody response following …